Search
Spring has come back to the earth, and everything is brought back to life. From March 14 to 16, the 9th ENMORE Biotechnology Industry Conference had been grandly held at Suzhou International Expo Center This exhibition invited more than 500 exhibiting institutions. 50,000 m2 bioindustry exhibition was co-established, serving nearly 30,000 professional audiences with five professional exhibition halls and creating value for co-building the biopharmaceutical industry supply chain.
Exhibition highlights
Morimatsu has gained sophisticated insight into the industry trends, and has been deeply dedicated to process innovation. At this exhibition, the Company still became the focus of attention for the entire audience by presenting the Laboratory One-Stop Turnkey Solution and VR Simulation Training System, which has received extensive attention and high recognition.
Laboratory One-Stop Turnkey Solution
It includes the upstream culture solution, downstream separation and purification solution, and disposable system solution.
Morimatsu has built a robust, reliable, streamlined and efficient process flow, which assists customers in significantly improving R&D efficiency, better coping with challenges at different stages, thus creating greater value and accelerating the provision of treatment plans for patients.
VR Simulation Training System
The Morimatsu VR simulation training system appealed to audiences overwhelmingly and attracted them to the booth with immersive experiences it brings to all. This system not only provides users with present-on-the-scene senses of participation through diverse interaction methods, but also reduces safety risks and costs during the training process, significantly improving training efficiency.
Cooperation and exchange, creating and enjoying a bright future
During the exhibition, Morimatsu had various business talks with industry counterparts, exchanged and discussed opportunities and challenges that the industry is facing, collected frontier ideas, brainstormed with wisdoms, and attracted the attention from plenty of potential partners. At the same time, Morimatsu has gained an insight towards market demands, listened to customer suggestions, and searched for a fit point for common development.
The global biopharmaceutical industry is presenting a trend of rapid development, which makes issues such as how to improve production efficiency and reduce production and operating costs, etc. receives a great concern. Morimatsu fully utilizes the powerful driving force of technological innovation, relies on superb technical strength and profound industry experience to accurately solve customer problems and provide higher quality products and more solid service guarantees.
Reforming the old and exploring the new, the 2024EBC has come to a successful end. In the meanwhile, Morimatsu will continue to energetically work for the sustained development and transformation upgrading of the industry, contributing more to promoting the cause of Human Comprehensive Health.
About Morimatsu LifeSciences
Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.
As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacture plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.
Forward-Looking Statements
The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.
Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.
